Korea reviews vision loss warnings for 38 GLP-1 products after US FDA action

Coverage, in order

1. 1d ago
   Korea Biomedical Review South Korea obscure

   Korea reviews vision loss warnings for 38 GLP-1 products after US FDA action

   Korea's drug regulator said Wednesday that it is considering broader safety warnings for GLP-1-based obesity and diabetes treatments following a U.S. FDA decision to require warnings about a rare eye condition that can cause permanent vision loss.The Ministry of Food and Drug Safety (MFDS) said it h

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.